179 related articles for article (PubMed ID: 33122887)
1. Metabolic Activation and Covalent Protein Binding of Berberrubine: Insight into the Underlying Mechanism Related to Its Hepatotoxicity.
Wang K; Rao J; Zhang T; Gao Q; Zhang J; Guang C; Ding L; Qiu F
Drug Des Devel Ther; 2020; 14():4423-4438. PubMed ID: 33122887
[TBL] [Abstract][Full Text] [Related]
2. In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine.
Yang N; Sun RB; Chen XL; Zhen L; Ge C; Zhao YQ; He J; Geng JL; Guo JH; Yu XY; Fei F; Feng SQ; Zhu XX; Wang HB; Fu FH; Aa JY; Wang GJ
Acta Pharmacol Sin; 2017 Mar; 38(3):351-361. PubMed ID: 28042874
[TBL] [Abstract][Full Text] [Related]
3. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
[TBL] [Abstract][Full Text] [Related]
4. High fat diet aggravates the nephrotoxicity of berberrubine by influencing on its pharmacokinetic profile.
Yang N; Sun R; Zhao Y; He J; Zhen L; Guo J; Geng J; Xie Y; Wang J; Feng S; Fei F; Liao X; Zhu X; Wang H; Fu F; Aa J; Wang G
Environ Toxicol Pharmacol; 2016 Sep; 46():319-327. PubMed ID: 27525563
[TBL] [Abstract][Full Text] [Related]
5. A rapid method for simultaneous quantification of berberine, berbamine, magnoflorine and berberrubine in mouse serum using UPLC-MS/MS.
Liang X; Xiang Y; Li Y; Feng P; Qin Y; Lai X
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Apr; 1142():122040. PubMed ID: 32145638
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of furan moiety makes Diosbulbin B hepatotoxic.
Li W; Lin D; Gao H; Xu Y; Meng D; Smith CV; Peng Y; Zheng J
Arch Toxicol; 2016 Apr; 90(4):863-72. PubMed ID: 25851819
[TBL] [Abstract][Full Text] [Related]
7. Dictamnine-induced hepatotoxicity in mice: the role of metabolic activation of furan.
Shi F; Pan H; Cui B; Li Y; Huang L; Lu Y
Toxicol Appl Pharmacol; 2019 Feb; 364():68-76. PubMed ID: 30578885
[TBL] [Abstract][Full Text] [Related]
8. Investigation of dose-dependent effects of berberine against renal ischemia/reperfusion injury in experimental diabetic rats.
Kumaş M; Eşrefoğlu M; Karataş E; Duymaç N; Kanbay S; Ergün IS; Üyüklü M; Koçyiğit A
Nefrologia (Engl Ed); 2019; 39(4):411-423. PubMed ID: 30712966
[TBL] [Abstract][Full Text] [Related]
9. ¹H-NMR-Based Metabonomics of the Protective Effect of Coptis chinensis and Berberine on Cinnabar-Induced Hepatotoxicity and Nephrotoxicity in Rats.
Su G; Wang H; Gao Y; Chen G; Pei Y; Bai J
Molecules; 2017 Nov; 22(11):. PubMed ID: 29099071
[No Abstract] [Full Text] [Related]
10. Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease
Yang S; Cao S; Li C; Zhang J; Liu C; Qiu F; Kang N
Front Pharmacol; 2022; 13():913378. PubMed ID: 35873595
[TBL] [Abstract][Full Text] [Related]
11. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats.
Mehrzadi S; Fatemi I; Esmaeilizadeh M; Ghaznavi H; Kalantar H; Goudarzi M
Biomed Pharmacother; 2018 Jan; 97():233-239. PubMed ID: 29091871
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Epoxidation Is a Critical Step for the Development of Benzbromarone-Induced Hepatotoxicity.
Wang H; Peng Y; Zhang T; Lan Q; Zhao H; Wang W; Zhao Y; Wang X; Pang J; Wang S; Zheng J
Drug Metab Dispos; 2017 Dec; 45(12):1354-1363. PubMed ID: 29021351
[TBL] [Abstract][Full Text] [Related]
14. Identification of berberrubine metabolites in rats by using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Wang K; Qiao M; Chai L; Cao S; Feng X; Ding L; Qiu F
Fitoterapia; 2018 Jan; 124():23-33. PubMed ID: 28993283
[TBL] [Abstract][Full Text] [Related]
15. Hepatotoxicity of ketoconazole in Sprague-Dawley rats: glutathione depletion, flavin-containing monooxygenases-mediated bioactivation and hepatic covalent binding.
Rodriguez RJ; Buckholz CJ
Xenobiotica; 2003 Apr; 33(4):429-41. PubMed ID: 12745877
[TBL] [Abstract][Full Text] [Related]
16. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
Gómez-Lechón MJ; Tolosa L; Donato MT
J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling.
Vivoli E; Cappon A; Milani S; Piombanti B; Provenzano A; Novo E; Masi A; Navari N; Narducci R; Mannaioni G; Moneti G; Oliveira CP; Parola M; Marra F
Clin Sci (Lond); 2016 Oct; 130(20):1793-806. PubMed ID: 27439970
[TBL] [Abstract][Full Text] [Related]
18. Glutathione Conjugation and Protein Adduction Derived from Oxidative Debromination of Benzbromarone in Mice.
Wang H; Wang W; Gong B; Wang Z; Feng Y; Zhang W; Wang S; Peng Y; Zheng J
Drug Metab Dispos; 2019 Nov; 47(11):1281-1290. PubMed ID: 31484654
[TBL] [Abstract][Full Text] [Related]
19. Metabolites identification of berberine in rats using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Wang K; Chai L; Feng X; Liu Z; Liu H; Ding L; Qiu F
J Pharm Biomed Anal; 2017 May; 139():73-86. PubMed ID: 28279930
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhetinic acid ameliorates diosbulbin B-induced hepatotoxicity in mice by modulating metabolic activation of diosbulbin B.
Lin D; Liu J; Chang X; Yang B; Gu X; Li W
J Appl Toxicol; 2023 Aug; 43(8):1139-1147. PubMed ID: 36807597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
